Cancer treatment: study finds targeting nearby ‘normal’ cells could improve survival rates
Ingo Ringshausen, University of Cambridge Cancer of the immune system, lymphoma or leukaemia, generally affects…
Browsing: Lymphoma
Protein inhibitor shown as potential treatment approach for common mutations found in non-Hodgkin lymphomas
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations A study at The…
Lymphoma patients may have new path to remission, even when CAR T therapy fails
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant…
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
A new analysis shows that a donor stem cell transplant following treatment with an immune…
Multidisciplinary transplantation evaluation shows promise for older adults with blood cancers
Older adults with blood cancers can benefit from a team-based, holistic evaluation before undergoing transplantation,…
Precisely poking cells en masse to cure cancer
What if you could cure cancer by re-engineering patients’ cells to better target and destroy…
Lasting tumour regression of leukaemia and lymphoma in mouse models achieved by U-M compound
For decades, a transcription factor known as STAT3 has been a major therapeutic target in…
Researchers discover enzyme’s role in ‘natural killer T cell lymphoma’
Natural killer T cell lymphoma (NKTL) is an aggressive form of cancer with very poor…
Blood cancers: New generation stem cell transplant significantly reduces complications for patients
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines…
Viagra and plerixafor show promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem…